Recent news on Eprex

EMEA to re-examine epoetins over cardiac fears  -  May 8, 2007
BiopharmaReporter.com,Several big pharma firms have epoetins on the market, such as Amgen's Aranesp (darbepoetin alfa) and Epogen (epoetin alfa); Ortho Biotech's Eprex (epoetin

Europe starts safety review of anemia drugs  -  Apr 27, 2007
MarketWatchEprex is known by the name Procrit in the United States. "The safety review has been initiated because new data from both unpublished and published studies

Amgen knocked back as EPO competition looms  -  May 17, 2007
BiopharmaReporter.com,...is gaining momentum there to the biotechnology giant's licensing partner Johnson & Johnson, which sells epoetin alfa there as Procrit and Eprex.

FDA says may need to limit use of anemia drugs  -  May 9, 2007
MarketWatchJ&J reported 2006 combined sales of $3.2 billion for Procrit and Eprex - a related drug marketed outside the US. There was mixed reaction to the FDA

To Cancer Patients on Anemia Drugs  -  May 8, 2007
Wall Street Journal (subscription),...sales and $2.5 billion in Epogen sales. J&J reported 2006 combined sales of $3.2 billion for Procrit and Eprex -- a related drug marketed outside the US.

Hemoglobin-boosting drugs potentially harmful: Health Canada  -  Apr 20, 2007
Canada.com,Two brands, Aranesp and EPREX, are authorized for use in Canada. Their manufacturers are updating safety information and labelling on the drugs.

J&J profits higher despite lower stent sales  -  Apr 17, 2007
MSNBC...tiny mesh tubes used to prop open coronary arteries, and anti-anaemia treatments Procrit/Eprex - are facing significant safety questions.

Healthy Prognosis at Johnson & Johnson  -  Apr 18, 2007
Motley FoolFools might be tempted to worry about challenging drug-eluting stent trends that are also hitting Boston Scientific (NYSE: BSX), Procrit/Eprex drug sales as

Johnson & Johnson Reports 2007 First-Quarter Results: Sales ...  -  Apr 17, 2007
PR Newswire (press release),Intl 187 215 -13% -18% 5% WW 303 325 -7% -10% 3% EPREX/PROCRIT US 530 527 1% 1% -- Intl 287 259 11% 4% 7% WW 817 786 4% 2% 2% Hormonal Contraceptives US

Death Risk in Lung-Cancer Patients  -  Apr 19, 2007
Wall Street Journal (subscription),Johnson & Johnson's Procrit and Eprex also fall into this category. "I think what this does commercially with Aranesp is it stabilizes use patterns," Baird

Analysis: J&J Q1 clouded on stent worries  -  Apr 17, 2007
United Press InternationalGlobal sales of Procrit/Eprex rose only 4 percent to $817 million, while US sales saw a 1 percent increase to $530 million.

Kidney-Disease Group Advises  -  Apr 12, 2007
Wall Street Journal (subscription),J&J's combined sales of Procrit and Eprex -- the brand sold overseas -- were $3.2 billion. Safety concerns about the drugs have contributed to a 15% decline

Dr. Waxman's Drug Lab  -  Apr 9, 2007
Wall Street Journal (subscription),In the late 1990s, Johnson & Johnson sold a licensed version of Amgen's dialysis drug Epogen, called Eprex in Europe. Several hundred patients developed a

Billion dollar babies—biotech drugs as blockbusters  -  Apr 3, 2007
Nature.com (subscription),New Jersey, respectively, also manufactured and sold in Europe by Ortho as Eprex) and up-and-comer Avastin (bevacizumab, for metastatic colon cancer),

The Next Big Bargain  -  Apr 2, 2007
Motley FoolThe Food and Drug Administration and the Department of Justice launched a criminal investigation into the quality of its anti-anemia drug Eprex after the

Epoetin Alfa May Decrease Survival in Anemic Patients with NSCLC  -  27 Mar 2007
Cancer Consultants (press release),One randomized breast cancer study of Eprex vs placebo was terminated early due to a 6% lower one year survival in the Eprex group.[2] A randomized trial of

Will Biotechs Pay the Price for Playing in the Big Leagues?  -  Mar 15, 2007
Seeking Alpha,Johnson & Johnson (JNJ) executives were quoted as saying a problem with Eprex, a brand name version for one of JNJ's erythropoietins, a few years ago,

Johnson & Johnson "neutral weight," estimates reduced  -  Mar 13, 2007
newratings.comIn a research note published yesterday, the analyst mentions that the labels on Procrit/Eprex drugs have been modified by the FDA to include a warning

GPhA Rebuttal On Dr. Siegel's Comments At Hearing  -  Mar 13, 2007
Medical News Today (press release),Siegel's use of Eprex is both alarmist and incomplete. Changes in the formulation of Eprex were allowed in Europe, using then-European standards.

Ortho Biotech in Discussions with FDA Regarding Prescribing ...  -  Mar 1, 2007
PharmaLive.com (press release),These data may have an impact on labeling in other parts of the world for EPREX(R) (Epoetin alfa), which is marketed by Janssen-Cilag.

Roche stock falls on anaemia drug delay  -  Feb 26, 2007
ReutersN: Quote, Profile, Research) Procrit and Eprex. "This news could be slightly negative for Roche certificates in the short term," Zuercher Kantonalbank

For Booming Biotech Firms, A New Threat: Generics  -  Mar 13, 2007
Wall Street Journal (subscription),J&J sells a version of Epogen in Europe under the brand name Eprex. A few years ago about 200 patients on Eprex developed serious immune reactions.

Amgen Under Fire From Congress  -  Mar 21, 2007
Forbes,Johnson and Johnson's revenues from Procrit and Eprex--the brand name for Procrit overseas--were $3.2 billion in 2006, making it the company’s

Studies Show Anemia Drugs May Harm Cancer Patients  -  Feb 27, 2007
New York Times,Under license from Amgen, Johnson & Johnson sells Procrit in the United States and Eprex abroad, with combined sales last year of $3.2 billion.

Shire undercuts rivals with launch of Dynepo drug  -  Mar 15, 2007
Reuters.uk,N: Quote, Profile , Research) Erypo/Eprex, Amgen Inc's (AMGN.O: Quote, Profile , Research) Aranesp and Roche Holding AG's (ROG.

Roche suspends phase II trial of its anemia drug  -  Feb 27, 2007
Earthtimes.orgIts another drug, Epogen, and Johnson & Johnson's drugs Procrit and Eprex also belong to this class. There are 153 patients who are participating in the

UPDATE 4-Roche suspends enrollment in anemia drug trial  -  Feb 23, 2007
ReutersN: Quote, Profile , Research) Procrit and Eprex. Roche said it is temporarily suspending recruitment into a mid-stage trial of Cera in anemic lung cancer

Greater caution on anemia drugs seen after deaths  -  Jan 29, 2007
Scientific AmericanLike Johnson & Johnson's rival drugs Eprex and Procrit, and Amgen's older Epogen, Aranesp's active ingredient is a natural protein called erythropoietin

Greater Caution on Anemia Drugs Seen After Deaths  -  Jan 30, 2007
Cancerpage.com,Like Johnson & Johnson's rival drugs Eprex and Procrit, and Amgen's older Epogen, Aranesp's active ingredient is erythropoietin (EPO).

RPT-UPDATE 1-Greater caution on anemia drugs seen after deaths  -  Jan 29, 2007
ReutersN: Quote, Profile , Research) rival drugs Eprex and Procrit, and Amgen's older Epogen, Aranesp's active ingredient is a natural protein called

Bridling at Insulin’s Cost, States Push for Generics  -  Jan 12, 2007
Wilmington Morning Star,One cautionary tale about the sensitivity of biologic production involves Eprex, an anti-anemia drug Johnson & Johnson marketed in Europe.

McGuinty Government Improves Access To Drugs  -  Dec 20, 2006
CNW Telbec (Communiqués de presse),Aranesp (Cancer chemotherapy-related anemia) - Eprex (Cancer chemotherapy-related anemia) - Trelstar (Prostate Cancer) - Gleevec (Cancer-treatment of

McGuinty Government Improves Access To Drugs  -  Dec 20, 2006
CNW Telbec (Communiqués de presse),Aranesp (Cancer chemotherapy-related anemia) - Eprex (Cancer chemotherapy-related anemia) - Trelstar (Prostate Cancer) - Gleevec (Cancer-treatment of

Gérard Pons Voyages sets sail with Dialysis while Cruising  -  Nov 27, 2006
French Technology Press Bureau (subscription),The on-board dialysis unit cannot dispense Eprex; patients requiring this drug must bring their own supply. There is no meal service in the ship’s hospital

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional